[Collagen diseases and rheumatic diseases]

Nihon Naika Gakkai Zasshi. 2004 Mar 10;93(3):538-44. doi: 10.2169/naika.93.538.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid*
  • Autoimmunity
  • Drug Therapy, Combination
  • Genes, T-Cell Receptor delta
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Isoxazoles / pharmacology
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Lupus Erythematosus, Systemic* / epidemiology
  • Lupus Erythematosus, Systemic* / etiology
  • Lupus Erythematosus, Systemic* / therapy
  • Lymphocytes / immunology
  • Methotrexate / therapeutic use
  • Prednisolone / administration & dosage
  • Prognosis
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Isoxazoles
  • Tumor Necrosis Factor-alpha
  • Prednisolone
  • Infliximab
  • Leflunomide
  • Methotrexate